CYD vs OMDA
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
CYD · China Yuchai International$19.62 ▼ 8.19%
OMDA · Omada Health$11.87 ▼ 5.04%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- CYD -42.7%
- OMDA -34.6%
Head to head
| Metric | CYD | OMDA |
|---|---|---|
| Price | $19.62 | $11.87 |
| Change today | ▼ 8.19% | ▼ 5.04% |
| Market cap | $736.11M | $736.39M |
| Return, 3 months | -49.4% | -50.7% |
| Return, year to date | -43.6% | -24.8% |
| Return, 1 year | -42.0% | -36.2% |
| P/E (TTM) | 6.7 | 52.5 |
| P/B | 0.5 | 2.7 |
| P/E percentile vs own 5y | 6th | 81st |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +34.7% | +34.2% |
| Net profit growth (YoY) | +62.6% | +306.1% |
| Gross margin | 16.5% | 70.7% |
| Operating margin | 4.0% | 2.1% |
| Net margin | 2.2% | 4.2% |
| Return on equity | 5.7% | 5.7% |
| Analyst target vs. price | +205.8% | +133.1% |
| Analyst buy share | 100% | 89% |
| RSI (14) | 30 | 23 |
| 30-day volatility | 51.5% | 95.7% |
| Max drawdown, 1 year | -66.5% | -52.5% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- OMDA is the largest of the group by market value.
- OMDA has returned the most over the past year.
- CYD carries the lowest trailing P/E.
- CYD is growing revenue fastest.
- OMDA keeps the most profit per dollar of sales.
- CYD has been the calmest stock over the last 30 days.